COMBINATION CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR REFRACTORY OVARIAN-CARCINOMA - IMPACT ON SURVIVAL

被引：0
|
作者：
MARKMAN, M
HOWELL, SB
机构：
[1] MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA
[2] UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A882 / A882
页数：1
相关论文
共 50 条
  • [31] CISPLATIN-BASED COMBINATION CHEMOTHERAPY IN CARCINOMA OF THE FALLOPIAN-TUBE
    BARAKAT, RR
    RUBIN, SC
    SAIGO, PE
    CHAPMAN, D
    LEWIS, JL
    JONES, WB
    HAKES, TB
    MARKMAN, M
    REICHMAN, B
    HOSKINS, WJ
    GYNECOLOGIC ONCOLOGY, 1991, 42 (02) : 156 - 160
  • [32] Intraperitoneal cisplatin-based chemotherapy versus intravenous cisplatin-based chemotherapy for stage III ovarian cancer with minimal residual disease: 10 years experience
    Yeng, MS
    Juang, CM
    Twu, NF
    Chao, KC
    7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 331 - 335
  • [33] Cisplatin-based combination chemotherapy consisting of ifomide, epirubicin, and cisplatin (IEP) is effective for patients with relapsed ovarian carcinoma (ROC) resistant or refractory to TC (paclitaxel/carboplatin)
    Murakami, F.
    Ogawa, N.
    Yamazaki, A.
    Yamada, M.
    Ishiya, T.
    Katase, K.
    Hasumi, K.
    Umezawa, S.
    Shimizu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] EVALUATION OF SURVIVAL AFTER 2ND-LINE INTRAPERITONEAL CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER
    PIVER, MS
    RECIO, FO
    BAKER, TR
    DRISCOLL, D
    CANCER, 1994, 73 (06) : 1693 - 1698
  • [35] Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer
    Recio, FO
    Piver, MS
    Hempling, RE
    Driscoll, DL
    GYNECOLOGIC ONCOLOGY, 1998, 68 (03) : 267 - 273
  • [36] Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy
    Eoh, Kyung Jin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Young Tae
    Kim, Sang Wun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (12) : 2021 - 2028
  • [37] LONG-TERM SURVIVAL OF ADVANCED REFRACTORY OVARIAN-CARCINOMA PATIENTS WITH SMALL-VOLUME DISEASE TREATED WITH INTRAPERITONEAL CHEMOTHERAPY
    HOWELL, SB
    ZIMM, S
    MARKMAN, M
    ABRAMSON, IS
    CLEARY, S
    LUCAS, WE
    WEISS, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1607 - 1612
  • [38] CISPLATIN, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (PACE) COMBINATION CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA RESISTANT TO CHLORAMBUCIL
    MEAD, GM
    WILLIAMS, CJ
    WHITEHOUSE, JM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 179 - 180
  • [39] SEQUENTIAL COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CARCINOMA
    GUNALE, SR
    MURALI, MS
    YODER, AS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 430 - 430
  • [40] DOXORUBICIN COMBINATION CHEMOTHERAPY IN OVARIAN-CARCINOMA - REPLY
    CONTE, PF
    BRUZZONE, M
    CHIARA, S
    RUBAGOTTI, A
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 681 - 681
12345